Yu Wang, Miao Huang, Gong Yunhui
Department of Gynecology and Obstetrics, West China Second University Hospital, Sichuan University, Chengdu, China.
Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second Hospital, Sichuan University, Chengdu, China.
J Diabetes Res. 2025 Mar 4;2025:3494697. doi: 10.1155/jdr/3494697. eCollection 2025.
Gestational diabetes mellitus (GDM) is a major health concern during pregnancy, affecting both the mother and the baby. Immune system alterations, particularly changes in lymphocyte subsets and cytokine profiles, have been associated with the pathophysiology of various metabolic disorders, including diabetes. This study is aimed at systematically reviewing the literature on the changes in lymphocyte subsets and cytokines in GDM. In this systematic review, we applied specific criteria to select observational studies (such as case-controls, cross-sectionals, or cohorts) that focused on pregnant women. We performed an extensive search across electronic databases, including Web of Science, Scopus, PubMed, MEDLINE, Embase, Cochrane Central Register of Controlled Trials, and Google Scholar, from January 1, 2010, to March 20, 2024. A total of 19 articles, with 2517 participants (1128 with GDM and 1389 without GDM), were included in the qualitative synthesis. Due to high heterogeneity among the articles, a meta-analysis was not conducted. The studies assessed 35 different lymphocyte subsets or proportions. The most commonly assessed subsets were CD3+ T cell (five articles, mostly no difference between GDM and non-GDM), CD4+ T cell (five articles with contradictory results), CD8+ T cell (four articles with contradictory results), B cell and NK cell (three articles, mostly no difference between GDM and non-GDM), and Tregs (three articles with contradictory results). Additionally, 32 cytokines or proportions were assessed in the studies. The most commonly assessed cytokines were IL-6 (eight articles, higher or similar levels in GDM compared to non-GDM), TNF- (seven articles, mostly higher or similar levels in GDM compared to non-GDM), IL-10 (six articles, mostly no difference between GDM and non-GDM), IL-2 (three articles, mostly no difference between GDM and non-GDM), and IFN- (three articles with contradictory results). According to the results, there were no significant changes in CD3+ T cells, B cells, NK cells, IL-10, and IL-2 in GDM. However, the levels of IL-6 and TNF- were higher or similar in GDM compared to non-GDM. The changes of other lymphocyte subsets and cytokines in GDM remained unclear.
妊娠期糖尿病(GDM)是孕期主要的健康问题,会影响母亲和胎儿。免疫系统改变,尤其是淋巴细胞亚群和细胞因子谱的变化,与包括糖尿病在内的各种代谢紊乱的病理生理学有关。本研究旨在系统回顾关于GDM患者淋巴细胞亚群和细胞因子变化的文献。在这项系统评价中,我们应用特定标准选择关注孕妇的观察性研究(如病例对照研究、横断面研究或队列研究)。我们在2010年1月1日至2024年3月20日期间,对包括科学网、Scopus、PubMed、MEDLINE、Embase、Cochrane对照试验中心注册库和谷歌学术在内的电子数据库进行了广泛检索。共有19篇文章、2517名参与者(1128名GDM患者和l389名非GDM患者)纳入定性综合分析。由于文章间异质性较高,未进行荟萃分析。这些研究评估了35种不同的淋巴细胞亚群或比例。最常评估的亚群是CD3 + T细胞(5篇文章,GDM和非GDM之间大多无差异)、CD4 + T细胞(5篇文章结果相互矛盾)、CD8 + T细胞(4篇文章结果相互矛盾)、B细胞和NK细胞(3篇文章,GDM和非GDM之间大多无差异)以及调节性T细胞(Tregs,3篇文章结果相互矛盾)。此外,研究中还评估了32种细胞因子或比例。最常评估的细胞因子是IL - 6(8篇文章,GDM中水平高于或与非GDM相似)、TNF - (7篇文章,GDM中大多高于或与非GDM相似)、IL - 10(6篇文章,GDM和非GDM之间大多无差异)、IL - 2(3篇文章,GDM和非GDM之间大多无差异)以及IFN - (3篇文章结果相互矛盾)。根据结果,GDM患者的CD3 + T细胞、B细胞、NK细胞、IL - 10和IL - 2无显著变化。然而,与非GDM相比,GDM中IL - 6和TNF - 的水平更高或相似。GDM中其他淋巴细胞亚群和细胞因子的变化仍不明确。